肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2020 ACR/NKF共识声明：肾脏病患者应用静脉钆造影剂

2020-11-10 美国放射学会 Radiology . 2020 Nov 10;

造影剂

2020年11月，美国放射学会(ACR)联合美国肾脏病基金会(NKF)共同发布了肾脏病患者应用静脉钆造影剂的共识声明。本文的主要目的是改善并规范肾脏病患者应用静脉钆造影剂的管理。

中文标题：

2020 ACR/NKF共识声明：肾脏病患者应用静脉钆造影剂

英文标题：

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

发布机构：

美国放射学会

发布日期：

2020-11-10

简要介绍：

2020年11月，美国放射学会(ACR)联合美国肾脏病基金会(NKF)共同发布了肾脏病患者应用静脉钆造影剂的共识声明。本文的主要目的是改善并规范肾脏病患者应用静脉钆造影剂的管理。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ACR_NKF共识声明：肾脏病患者应用静脉钆造影剂.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d16131c002012ee4, title=2020 ACR/NKF共识声明：肾脏病患者应用静脉钆造影剂, enTitle=Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation, guiderFrom=Radiology . 2020 Nov 10;, authorId=0, author=, summary=2020年11月，美国放射学会(ACR)联合美国肾脏病基金会(NKF)共同发布了肾脏病患者应用静脉钆造影剂的共识声明。本文的主要目的是改善并规范肾脏病患者应用静脉钆造影剂的管理。, cover=https://img.medsci.cn/20201126/1606320499823_2020535.jpg, journalId=0, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会（American College of Radiology）拥有会员超过34,000名，包括美国放射医师，放射肿瘤学家，物理学家介入医师及核医学医师。其指南按放射检查的方法分类，共十组，每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Tue Nov 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，美国放射学会(ACR)联合美国肾脏病基金会(NKF)共同发布了肾脏病患者应用静脉钆造影剂的共识声明。本文的主要目的是改善并规范肾脏病患者应用静脉钆造影剂的管理。</p> </div> </div> </div>, tagList=[TagDto(tagId=6661, tagName=造影剂)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6661, guiderKeyword=造影剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5248, appHits=122, showAppHits=0, pcHits=851, showPcHits=5126, likes=0, shares=12, comments=5, approvalStatus=1, publishedTime=Thu Nov 26 00:27:03 CST 2020, publishedTimeString=2020-11-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 26 00:08:35 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 05:54:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ACR_NKF共识声明：肾脏病患者应用静脉钆造影剂.pdf)])
2020 ACR_NKF共识声明：肾脏病患者应用静脉钆造影剂.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003495, encodeId=120c10034951a, content=学习了！很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/12314bd965904190996cd2d408f7c8ba/2034f5a22b4e46c0a8217aa5553d8fd6.jpg, createdBy=df6a5546458, createdName=云卷岭上, createdTime=Thu Jul 29 00:39:54 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952539, encodeId=a7b7952539a3, content=学习了，指导临床应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaf1405665, createdName=chuntianzihan, createdTime=Wed Mar 31 06:42:01 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916944, encodeId=ec4e91694464, content=好声明！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 15 16:56:45 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-07-29 云卷岭上

    学习了！很受用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003495, encodeId=120c10034951a, content=学习了！很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/12314bd965904190996cd2d408f7c8ba/2034f5a22b4e46c0a8217aa5553d8fd6.jpg, createdBy=df6a5546458, createdName=云卷岭上, createdTime=Thu Jul 29 00:39:54 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952539, encodeId=a7b7952539a3, content=学习了，指导临床应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaf1405665, createdName=chuntianzihan, createdTime=Wed Mar 31 06:42:01 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916944, encodeId=ec4e91694464, content=好声明！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 15 16:56:45 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-03-31 chuntianzihan

    学习了，指导临床应用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003495, encodeId=120c10034951a, content=学习了！很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/12314bd965904190996cd2d408f7c8ba/2034f5a22b4e46c0a8217aa5553d8fd6.jpg, createdBy=df6a5546458, createdName=云卷岭上, createdTime=Thu Jul 29 00:39:54 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952539, encodeId=a7b7952539a3, content=学习了，指导临床应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaf1405665, createdName=chuntianzihan, createdTime=Wed Mar 31 06:42:01 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916944, encodeId=ec4e91694464, content=好声明！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 15 16:56:45 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-01-15 jyzxjiangqin

    好声明！

    0

相关指南

2018 JSN/JRS/JCS指南：碘造影剂在肾脏病患者中的应用

日本肾脏病学会(JSN,Japanese Society of Nephrology) · 2019-11-11